Pharma & Biotech

A notable divergence has emerged in the trading activity surrounding biotech firm Incyte. The stock is climbing toward new peaks,...

Cellectar Biosciences is navigating a period of significant activity, marked by substantial advancements within its radiopharmaceutical pipeline and an enhanced...

Tobacco giant Altria may secure a significant competitive advantage in the rapidly expanding nicotine pouch market. In an unusual regulatory...

Investors seeking to lead a securities class action against Capricor Therapeutics must file their motions by September 15. This legal...

Shares of Danish pharmaceutical giant Novo Nordisk experienced continued pressure on Friday, puzzling observers who expected a positive market response...

Investors in French vaccine developer Valneva have experienced a period of extreme volatility, witnessing both significant setbacks and encouraging developments...

BioNTech has achieved a critical milestone in its oncology program, marking a significant advancement beyond its COVID-19 vaccine business. The...

While its high-profile legal battle with Apple Inc. continues to generate headlines, medical technology firm Masimo is simultaneously drawing significant...

Inari Medical Inc. and several of its former executives are mounting a vigorous defense against a class action lawsuit filed...

While 89bio continues to advance its key Phase 3 trial for its flagship drug candidate, Pegozafermin, the company has received...